Skip to main content
. 2023 Jul 7;201(2):307–316. doi: 10.1007/s10549-023-07009-8

Table 1.

Upregulated and downregulated genes for trilaciclib responders versus non-responders at baseline

Upregulated genes Downregulated genes
MAGEA3, MAGEA6, MAGEA12, CSAG1, OR8G1, PAGE2, BC011773, GABRA3, CSAG3, TMEM213, POTEG, MEF2B, ALOX12B, KRT81, BNC1, TF, BHLHA15, GTSF1, TUBB1, C4orf26, SPAG4, DIS3L, WHAMM TMEM237, TTLL7, KRT18, CRAT, CMBL, SNORA65, SLC7A2, ENPP3, SPTB, FGFR4, ABCC6, SOX11, AR, REEP6, RBM20, NEURL, ZNF729, TMEM45B, MAPT, TDRD1, CYP4Z1, AGR2, APOB, DEFB1, FAM5C, MUC2, ABCC11, ALB, TFAP2B, DLK1, FGB, FGG, CRISP3, ZFP42, FLG, CDSN, UGT2B11, DIO1, MUCL1, SLC26A3, IRS4, CLCA2, FLG2, UGT2B10, LOC652203, RP11-1186N24.5